Ingelheim
Germany
24
2011-03-17
The entities that hold a legal rights for patent applications filed by inventor TRUNK Michael:
Michael TRUNK from Ingelheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
BLISTER FOR INHALERS
#2 | 2010-10-28RADIOLABELLED MICROPARTICLES, PROCESSES FOR THE PREPARATION THEREOF AND THE USE THEREOF
#3 | 2010-09-16POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS
#4 | 2010-08-26Micronization method
#5 | 2010-07-29Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier
#6 | 2010-07-27Tiotropium containing powder formulation for inhalation
#7 | 2010-03-04Stable powder formulation containing an anticholinergic agent
#8 | 2010-02-25Stable powder formulation containing a novel anticholinergic agent
#9 | 2009-12-17Encapsulated tiotropium containing powder formulation for inhalation
#10 | 2007-12-18Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
#11 | 2007-02-08Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate
#12 | 2007-01-18Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
#13 | 2006-10-05Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
#14 | 2006-06-22Blister for inhalers
#15 | 2006-06-08Surface modification of lactose excipient for use in powders for inhalation
#16 | 2006-06-01Powdered inhalants based on modified lactose mixtures as excipient
#17 | 2005-10-13Anticholinergic powder formulations for inhalation
#18 | 2005-07-07Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
#19 | 2005-06-21Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
#20 | 2005-05-31Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
#21 | 2005-02-24Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
#22 | 2005-02-24Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder
#23 | 2005-02-24Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
#24 | 2005-02-24Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
3355049 ⎘